UMN Medical School Discovery Could Mean Improved Immunity Against Reinfections
MINNEAPOLIS, MN- July 10, 2018- For years, researchers have had an established viewpoint of the function of a unique protein in the body called purinergic receptor P2RX7 that triggers the innate immune response. It was considered a “bad thing” and therefore blocked. Now, University of Minnesota researchers have discovered a connection between the body’s memory cells and this protein, influencing the body’s long-term immune system.
“If you get rid of the P2RX7 protein, you lose the generation of these memory cells,” explained Stephen Jameson, PhD, Professor and Chairman's Fund Professorship in Experimental Pathology, Department of Laboratory Medicine and Pathology, University of Minnesota Medical School. “It turns out this protein is a good thing for the adaptive immune system.”
Once the memory cells are created, they remain for years protecting the body from certain viruses and reinfection. However, during their studies, researchers also discovered there was a way to lose that immune protection against infections.
“We found when certain drugs are used to control neuropathic chronic pain in mice, immune memory cells start to decay,” said Jameson. “Suddenly you could be vulnerable to infections you shouldn’t be vulnerable to anymore.”
This data, published in Nature, was a collaboration of several UMN researchers including Henrique Borges da Silva, PhD, Center for Immunology, University of Minnesota Medical School. This finding could be beneficial to pharmaceutical companies, as well as to other researchers. Among other questions, it allows them to start asking and looking into such things as how to target neuropathic pain while leaving the immune system alone.
About the University of Minnesota Medical School
The University of Minnesota Medical School is at the forefront of learning and discovery, transforming medical care and educating the next generation of physicians. Our graduates and faculty produce high-impact biomedical research and advance the practice of medicine. Visitmed.umn.edu to learn how the University of Minnesota is innovating all aspects of medicine.
Contact: Krystle Barbour
You may also like:
A first of its kind discovery could mean new understandings in non-alcoholic fatty liver disease.
Dr. Emily Onello is honored as a 2018 Community Star for her contributions and positive impact on rural lives.
Endowment from Lupus Link Minnesota helps Center for Autoimmune Diseases Research to focus on systemic lupus.